Double Blinded, Randomized, Placebo-controlled Clinical Study for Nelumbinis Semen

Stress Clinical Trial

Official title:

Double Blinded, Randomized, Placebo-controlled Clinical Study for Evaluating Anti-stress Effects of Nelumbinis Semen by 2 Week Administration

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03973099
• Other study ID #: KCMC07OT066
• Status: Completed
• Phase: N/A
• Start date: June 7, 2007
• Est. completion date: December 30, 2007

Study information

• Verified date: June 2019
• Source: GMP BIO Co., LTD.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Nelumbinis Semen, has been widely used as treatment of post-menopause symptoms in women for hundreds of years in many Asian countries. This study examines whether PM011, standardized herbal medicine made from Nelumbinis Semen, treats stress in above 5 of BDI score of human subjects and discusses its potential as treatment for depressed patients.

Description:

Nelumbinis Semen, has been widely used as treatment of post-menopause symptoms in women for hundreds of years in many Asian countries. This study examines whether PM011, standardized herbal medicine made from Nelumbinis Semen, treats stress in above 5 of BDI score of human subjects and discusses its potential as treatment for depressed patients. Subjects were divided into three groups, the placebo-treated group (n = 10), the PM011-2.4 g treated group (n = 11) and PM011-4.8 g treated group (n = 11) per day. Alpha/Beta ratio of electroencephalogram (EGG), Beck Depression Inventory (BDI) and Stress Response Inventory (SRI) were conducted in order to measure changes in stress before and after 2 weeks of PM011 treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: December 30, 2007
• Est. primary completion date: December 30, 2007
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

<Inclusion Criteria>

• Volunteers were selected based on following meet conditions;Men and women, who have willingness and capacity to comply with the study protocol, are included if they were aged 18 to 65 years.

• Volunteers, who can understand Korean and English alphabet are selected.

• Volunteers, who can communicate with clinical trial performer fully, comply with the all tests and medical examinations performed by study protocol.

• All volunteers or their protectors understand purpose of study fully and sign their names or seal.

• Volunteers, who do not come under exclusion criteria are selected.

• BDI score of Volunteers, who can be >= 5.

<Exclusion Criteria>

• Volunteers were excluded if they are applied to following meet conditions; Volunteers with fasting glucose level over 126 mg/dl.

• Volunteers with hypertension as having over 140 mmHg of systolic blood pressure or 90 mmHg of diastolic blood pressure.

• Volunteers with blood thyroid stimulating hormone below 0.3 or over 4.0.

• Men with hemoglobin below 13.0 g/dl and women with hemoglobin below 12.0 g/dl.

• Volunteers with abnormality of liver function as having over 1.5 times of normal levels of ALT or AST.

• Patients with infections in upper airways or chronic diseases.

• Mental illness patients with such as alcoholism.

Related Conditions & MeSH terms

• Stress

Intervention

Dietary Supplement:
• PM011
PM011 is a 400 mg hard gelatin capsule containing water extracts of Nelumbinis Semen. The sprayed-dry extract of the herbal medicine used was purchased from Sun Ten pharmaceutical company in Taiwan. Each participant received twelve capsules of PM011, which divided into 2.4 g treatment or 4.8 g treatment group or placebo daily for two weeks and was instructed to take six capsules after breakfast and six capsules after dinner. Subjects in the placebo group received the equivalent amount of starch and lactose mixture capsules and administered with the same schedule.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
GMP BIO Co., LTD.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Beck Depression Inventory (BDI)	BDI is a 21 item, self rated inventory with each item rated with a set of four possible answer choices of increasing intensity.	Change from baseline BDI score at 2 weeks
Primary	Stress Response Inventory or Test (SRI or SRT)	SRI is highly reliable and valid, and that it is utilized as an effective measure of stress for research in stress-related fields in Korea. SRI is a total of 39 response items under the seven subscales. The seven subscales are divided into tension (A), aggression (B), somatization (C), anger (D), depression (E), fatigue (F), and frustration (G). When the test is scored, a value of 0 to 4 is assigned for each answer and then the total score is compared to a key to determine the stress's severity.	Change from baseline SRI or SRT score at 2 weeks
Secondary	Alpha/beta ratio of electroencephalogram (EEG)	Electroencephalogram (EEG) is used to measure the brain waves. Each wave pattern is associated with different mood state and state of consciousness. Alpha is one of four basic brain waves (delta, theta, alpha and beta) which make up the EEG. Alpha is seen in wakefulness where there is relaxed and effortless alertness. Beta is seen in highly stressful situations, and where there is difficult mental concentration and focus. Therefore, high alpha and less beta waves have been used as indices of relaxation, arousal, anti-stress, and better concentration.	Change from baseline Alpha/beta ratio of electroencephalogram (EEG) at 2 weeks